Reason: HCC tx TACE/RFA increasing AFP reassess History: HCV cirrhosis ABDOMEN:LIVER, BILIARY TRACT: Nodular cirrhosis with widening of the fissures. Hepatic steatosis and areas of fibrosis. Patent hepatic vasculature. Stable single small gallstone. No biliary dilatation. Segment 1 ablation cavity measuring up to 2.8 x 2.1 cm, previously 2.8 x 2.1 cm (series 1203/70). New nodular marginal recurrence at the inferior aspect of the ablation cavity, particularly posteriorly and medially. The area of recurrence demonstrates arterial hyperenhancement with washout and restricted diffusion. For future reference, the largest nodule is seen posteriorly along the ablation cavity measures up to 1.7 x 1 cm (series 1201/67). Additional smaller nodules with similar signal characteristics are seen more medially along the ablation cavity.Stable segment 8 lesion without significant enhancement measuring 1.1 x 1.0 cm, previously 1.1 x 1 cm (series 1203/77). SPLEEN: Splenomegaly. Stable nonspecific septated anterior splenic hypodensity.PANCREAS: Stable small, nonspecific cystic lesion in the uncinate process, which could be due to a branch type IPMN.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Bilateral subcentimeter T2 hyperintensities, likely cysts, stable.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1. Segment 1 ablation cavity with marginal recurrence as detailed above. There are multiple small lesions around the cavity that are suspicious for HCC2. Stable nonspecific cystic lesion in the uncinate process.